- Home
- FABC vs LSTA Comparison
FABC vs LSTA Comparison
Compare FABC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FABC | LSTA |
|---|---|---|
| Founded | 1997 | 1980 |
| Country | United States | United States |
| Employees | 108 | N/A |
| Industry | Telecommunications Equipment | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0M | 15.9M |
| IPO Year | 1999 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FABC | LSTA |
|---|---|---|
| Price | $2.00 | $1.00 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 93.8K | 78.9K |
| Earning Date | 11-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | N/A | ★ N/A |
| Revenue | $4,579,745.00 | ★ $35,283,868.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 56.90 |
| 52 Week Low | $2.02 | $0.96 |
| 52 Week High | $4.57 | $5.07 |
Technical Indicators
Market Signals| Indicator | FABC | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 35.85 | 34.39 |
| Support Level | N/A | $0.99 |
| Resistance Level | $2.49 | $1.28 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 0.00 | 11.02 |
Price Performance
Historical ComparisonAbout FABC Fabric.AI Inc. Common Stock
Fabric.AI Inc is an infrastructure company building a suite of fabless semiconductor technologies to power AI factories - smart data centers optimized for producing intelligence at scale. The company's innovations include MicroLED-based optical interconnects and other system-critical technologies that enable faster, more efficient, and more scalable AI workloads. Its mission is to transform data centers into unified production systems for artificial intelligence.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.